A scientific review board has closed down the oral tenofovir arm of the Vaginal and Oral Interventions to Control the Epidemic (VOICE) study looking at pre-exposure prophylaxis (PrEP) HIV prevention interventions among women in Africa. The Microbicides Trial Network, responsible for the study, made the announcement Wednesday. VOICE is the first study to compare the […]
The following is a guest blog post by Mitchell Warren, executive director of AVAC – Global Advocacy for HIV Prevention. Recent news about HIV/AIDS has focused on the good – promising trial results that prove the same antiretroviral (ARV) drugs used to treat HIV can also prevent HIV infections; and the bad – retreats in […]
MSNBC “Hardball” host Chris Matthews interviewed Director of the National Institute of Allergy and Infectious Disease at the National Institutes of Health Dr. Anthony Fauci at a Capitol Hill briefing Tuesday in commemoration of 30 years of the AIDS pandemic, hosted by the Foundation for AIDS Research (amfAR).
The interview covers topics from the latest scientific developments in combating the disease, challenges to maintaining federal funding, and an assessment of President Obama’s leadership in the fight against AIDS.
The following Q & A with Kenyan Ob/Gyn Dr. Elizabeth Anne Bukusi, chief research officer and deputy director of research and training at the Kenya Medical Research Institute, covers topics from microbicide trials and challenges to roll-out and medical male circumcision to condom stock-outs and PEPFAR funding. Dr. Bukusi travelled to the U.S. to speak at an event this week discussing how the U.S. can advance global health through new technologies, hosted by the Global health Technologies Coalition Tuesday on Capitol Hill. Read more…
The following is a guest blog post by Jim Pickett, chair of International Rectal Microbicides Advocates (IRMA) and director of Prevention Advocacy and Gay Men’s Health at the AIDS Foundation of Chicago.
Since 2005, our network of more than 1,000 scientists, advocates, policymakers, and funders from six continents that makes up International Rectal Microbicide Advocates (IRMA), has advocated for the accelerated research and development of safe, effective, acceptable and accessible rectal microbicides for the women, men, and transgender individuals around the world who engage in anal intercourse…. (Read More)
Nelson L. Michael is a medical doctor, has a doctorate in molecular biology, holds the rank of colonel in the U.S. Medical Corps and his day job is huge: He is in charge of the U.S. Military HIV Research Program at the Walter Reed Army Institute of Research in Rockville, Md. He oversees 750 people and his budget this year was $180 million.
But Michael is low-key to the core, and much of his job escapes public notice, even if he now is following multiple leads that resulted from a Thailand HIV vaccine study, which showed in 2009 for the first time that a preventive HIV vaccine was possible.
Often his job is figuring out how to make things work for research, and that has led him to Mozambique a couple of times in recent months to talk about starting a clinical trial site for HIV vaccine research…
Kevin M. DeCock, MD, is director of the Center for Global Health at the Centers for Disease Control and Prevention (CDC), based in Atlanta. Among his past positions are Director of CDC Kenya and Director of the World Health Organization’s Department of HIV/AIDS. John Donnelly talked with Dr. DeCock Thursday about the large numbers of […]
Quarraisha Abdool Karim, PhD, is an infectious diseases epidemiologist whose research involves understanding the evolving HIV epidemic in South Africa; factors influencing acquisition of HIV infection in adolescent girls; and sustainable strategies to introduce antiretroviral medicines in resource-constrained settings. She is an associate professor of Clinical Epidemiology at Columbia University’s Mailman School of Public Health […]
Kaitlin Christenson is coalition director for the Global Health Technologies Coalition (GHTC), an organization with more than three dozen member-groups that work on neglected diseases, including HIV/AIDS and tuberculosis. The coalition, formalized just two years ago, advocates for more research and backs new U.S. policies to accelerate the development of new drugs, vaccines, diagnostics, and […]